Cronos Group Inc. (CRON)
Symbol Info
Listed Symbol CRON
Name Cronos Group Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $
Price Info
21 Day Moving Average $11.5233
21 Day EMA $11.829290
50 Day Moving Average $13.2118
50 Day EMA $12.931870
200 Day EMA $13.981960
200 Day Moving Average 15.533750
52 Week High $25.10
52 Week Low $6.50
52 Week Change $14.045499
Alpha 0.116572
Beta 3.0152
Standard Deviation 0.347950
R2 0.088743
Periods 38
Share Information
10 Day Average Volume 3,608,176
20 Day Average Volume 3,479,701
30 Day Average Volume 4,334,004
50 Day Average Volume 4,026,709
Outstanding Shares 341,238,088
Float Shares 341,238,088
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 377
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 7,033,805
Institute Holdings Percent 12.900000
Institute Sold Previous 3 Months 2,349,370
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $-0.4000006
7 Day Percent Change -3.35%
21 Day Price Change $0.1300001
21 Day Percent Change 1.14%
30 Day Price Change $-2.3900003
30 Day Percent Change -17.17%
Month To Date Price Change $0.5100
Month To Date Percent 4.63%
90 Day Price Change $-4.830001
90 Day Percent Change -29.52%
Quarter To Date $-4.45
Quarter To Date Percent -27.85%
180 Day Price Change $-9.61
180 Day Percent Change -45.46%
200 Day Price Change $-8.72
200 Day Percent Change -43.06%
Year To Date $1.139999
Year To Date Percent 10.97%
Profile
Description Cronos Group Inc., headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, COVE and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth.
Details
Issue Type CS
Market Cap $3,934,475,155
Sec Type EQS
Auditor KPMG LLP
Total Shares Outstanding 336,151,502
CEO Michael Gorenstein
Employees 291
Last Audit UE
Classification
CIK 0001656472
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 720 King Street West
Suite 320
Toronto, ON M5V 2T3
Website http://www.thecronosgroup.com
Facisimile
Telephone +1 416 504-0004
Email
Key Ratios
Profitability
EBIT Margin -143.2
EBITDA Margin -130
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin 85.40
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $0.0837
Revenue 3 Years $422.55
Revenue 5 Years $-
Valuation Measures
PE Ratio 5.70
Enterprise Value $1,767,329,798
Price To Sales 137.674960
Price To Free Cash -29
PE High Last 5 Years -
Price To Book 4.1
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 4.1
Financial Strength
Total Debt To Equity -
Int Coverage 23.5
Current Ratio 1.7
Leverage Ratio 2.2
Quick Ratio 1.6
Long Term Debt To Capital -
Assets
Receivables Turnover 1.8
Invoice Turnover 0.10
Assets Turnover -
Management Effectiveness
Return Assets 45.60
Return On Equity 91.39
Return On Capital 90.37
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
CRON
Cronos
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.